The Board of Jeil Pharmaceutical Co., Ltd. has authorized a buyback plan on November 7, 2013.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10,670 KRW | -1.57% | -3.87% | -9.35% |
2023 | Jeil Pharma Holdings Inc Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2022 | Jeil Pharma Holdings Inc's Equity Buyback Plan Extended till October 2, 2042. | CI |
1st Jan change | Capi. | |
---|---|---|
-9.35% | 122M | |
+22.69% | 43.81B | |
+24.92% | 23.01B | |
+18.00% | 15.27B | |
+8.91% | 13.68B | |
+42.72% | 11.96B | |
-7.21% | 6.98B | |
-0.05% | 6.79B | |
-8.87% | 5.73B | |
+12.22% | 5.59B |
- Stock Market
- Equities
- A002620 Stock
- News Jeil Pharma Holdings Inc
- Jeil Pharmaceutical Co., Ltd. authorizes a Buyback Plan.